Validation of a suite of ERP and QEEG biomarkers
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry led-study in subjects with schizophrenia and healthy volunteers.
View More Psychedelic Facilitators Undergo Certification Training
Our Clinical Sciences team, comprised of Dr. Larry Ereshefsky, Dr. Brett English, Dr. Robert Litman, along with Principal Investigators Dr. Djouher Hough, and Dr. Haig Goenjian, have developed fit
View More Placebo-Control Reminder Script
General medicine studies are not immune to the placebo effect, where 30-40% of patients report improved subjective and objective outcomes in general medical studies (Hrobjartsson & Gotzsche, 2001). The high
View More
CenExel Acquires Apex Innovative Sciences
[et_pb_section fb_built=”1″ _builder_version=”4.12.0″ global_colors_info=”{}”][et_pb_row _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”] Salt Lake City, June 16, 2022 /GlobeNewswire/ — CenExel announces
View More CenExel Acquires iResearch
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Salt Lake City, May 3, 2022 /GlobeNewswire/ —
View More CenExel Acquires Rocky Mountain Movement Disorders Center
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]Salt Lake City, January 11, 2022 /GlobeNewswire/ — CenExel Clinical Research,
View More CenExel Acquires California Neuroscience Research
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]Salt Lake City, January 10, 2022 /GlobeNewswire/ — CenExel Clinical Research,
View More Cali Biosciences Phase 2b Study on Post-Operative Pain
SAN DIEGO, August 12, 2021 /PRNewswire/ — Cali Biosciences Co., Ltd. (hereinafter referred to as “CaliBio”), a global biopharmaceutical company focused on the research and development of innovative drugs,
View More Females with Schizophrenia for Clinical Trials
Are you a woman living with schizophrenia? We have several clinical trials that might be just right for you. The trials are compensated if you qualify, and transportation is
View More Esketamine Receives Support from 2 FDA Committees
[et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.7.1″] Esketamine, a drug developed by Johnson & Johnson for the treatment of depression has received support from two
View More
